Back

Prognostic value of TAPSE/sPAP ratio across cardiovascular–kidney–metabolic phenotypes after TAVI

29 August 2026 (08:15 - 08:45)
Organised by: Logo
Congress Presentation Part of: Beyond the valve and vessel: systemic risk, inflammation, and complex interventions Aortic Valve Intervention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Kai Hu

University Hospital Wuerzburg, Wuerzburg (Germany)

4 More presentations in this session

Presentation thumbnail
Multi-level thromboinflammatory activation after TAVR: systemic, cellular, and platelet transcriptomic changes
Doctor D. Hesselbarth (Freiburg, DE)
Abstract
Presentation thumbnail
Culprit-only versus multivessel percutaneous coronary intervention in acute myocardial infarction complicated by cardiogenic shock: an updated systematic review and meta-analysis
Doctor V. Gomez Lopez (Mexico City, MX)
Abstract
Presentation thumbnail
Systemic atherosclerosis assessment using lipoprotein(a) and angioscopy: a prospective study of cholesterol crystal detection
Doctor Y. Tanaka (Tokyo, JP)
Abstract
Presentation thumbnail
Safety and efficacy of intravascular lithotripsy-facilitated transcatheter aortic valve replacement: a systematic review and meta-analysis
Doctor D. Chekhava (Bronx, US)
Abstract

Access the full session

Session thumbnail
Beyond the valve and vessel: systemic risk, inflammation, and complex interventions

The Event

Event poster

ESC Congress 2026

29 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Alternative to right catheterisation: prognostic value of the TAPSE/PSAP ratio in patients undergoing TAVI
15 March 2025
thumbnail
Congress Presentation
Chronic kidney disease impact after mitraclip therapy: five-year outcomes from the GRASP registry
1 July 2021
thumbnail
Congress Presentation
Prognostic value of cardiopulmonary exercise testing in valvular heart disease
27 August 2021
thumbnail
Congress Presentation
Prognostic significance of calibrated integrated backscatter in patients submitted to transcatheter aortic valve implantation
10 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources